小丹的空间
丹心也曾昭日月
博文
(2021-06-20 21:31:12)
"Inthesamespace,Anavex(AVXL)targetssigma-1receptorwithtwocandidates,2-73and3-71.Thereissomeimpressivedataforasub-groupofpatientswhohasbeenon2-73foroverfouryearswithoutsymptomdeterioration.Moreimportantly,2-73hasbeeninaregistrationtrialforADforovertwoyearsandmostlikelyisaheadofSAVAthreeyears."阅读全文]
(2021-06-20 13:59:41)
CASE#1 OnNov.9,2015,bothSafetyandEfficacydatawereannounced: https://www.anavex.com/anavex-announces-positive-primary-and-secondary-endpoints-were-achieved-in-a-phase-2a-clinical-trial-of-anavex-2-73-in-alzheimers-disease%E2%80%8E/ OnNov.3,2015,AVXLstockpricereacheditspeakof$14.84.Thiswasoneweekaheadoftheannouncement. ___________________________________________________ Case#2 OnJu...[阅读全文]
(2021-06-19 15:27:22)
Dr.ChristopherMissling'sinterviewinNov.21,2014,rightbeforeAnavexstarteditsPhase2studyofAnavex2-73onAltheimer'sDisease. ThecompletestocktrendofAVXLthereafter(Nov.2014-Nov.2015).PaycloseattentiontotheabruptfallafterAVXLbrieflyreachedthe$14.84peak.Manyinvestorswouldgettrappedthereforalongtime. Ifyoudon'thavethestomachforriskandstockvolatility,DONOTPLAYAVXL. Thisisnotinves...[阅读全文]
(2021-06-19 11:23:14)
LookatthesimilaritybetweenSAVA(rightbeforethesharpriseto>$110)andAVXL(today),thisisavolcanoabouttoerupt. [阅读全文]
(2021-06-18 20:48:19)
(2021-06-17 19:36:19)
(2021-06-16 19:29:57)
通过计算交易量，发现从6月10号至今，买入量(84M)远大于卖出量(69.3M),从6月11号到今天，总共有14.7M的净买入量。即使按最高27%左右的换手率算，也有11M左右的纯买入量。这段时间，ORPH股价从最初的$5.13涨到今天得收盘价$16.21，最高曾到过$77.77。 由此猜测： 因为ORPH的药被FDA批准的可能性很高，所以明天开盘后，买入量飙升的可能性较大，股价估计会spikeup。 Note：以上分[阅读全文]
(2021-06-15 17:40:20)
"IfDr.Misslingkeepstohisannouncedschedule,therewillbetwosignificantdatareleasesinthenext11tradingdays,andifthedataisasgoodasintimated,itwillbedetailedandverysupportiveoftwodrugcandidates.IMO,themarketisstillignoringtheobviousthatDr.MisslingisabouttoreleasetheKrakenandtheopportunitytodayishugetograbsomestockbeforeitismuchhigher.Justsaying,doyourduediligenceandweightherisk/reward."-byEnd2W...[阅读全文]
(2021-06-14 22:15:55)
看下面这个图。自从BIIB的aducanumab被FDA批准后，这个行业就像被打了鸡血，随便一点消息，各个AD药股的股价就噌噌噌的往上蹿。FDA开闸放水，各种投机资金闻风而动，正是摸鱼的好机会。 AVXL的CEOChristopherMissling估计也闻到了血腥味，所以就有了这条消息： https://www.anavex.com/anavex-life-sciences-reports-new-publication-in-medical-journal-elucidating-the-mechanism-of-anavex2-73-blarcamesine-and-anavex3-...[阅读全文]
(2021-06-14 20:31:04)
_______________________________________________________________________________________________ FromMay21,2021toJun.08,2021,becauseofBIIB,allADstockshaveincreasetheirMC: SAVA:+35%;ANVS:+30%;AVXL:+26%;CRTX:+15%;ATHA:+8% _______________________________________________________________________________________________ [阅读全文]
